Monograph Title Sort descending | Section | Source Publication | Page Number | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
CAFFEINE CITRATE ORAL SOLUTION | ASSAY/Procedure | USP38–NF33 | 2521 | 30-Jan-2015 | 1-Feb-2015 | USP39–NF34 | Second Supplement to USP38–NF33 | Line 5 of Analysis: Change Result = (rU/rS) × CS × (Mr1/Mr2) × 100 to: Result = (rU/rS) × C… Read More |
CAFFEINE CITRATE ORAL SOLUTION | Assay | USP36–NF31 | 2733 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 3 of Chromatographic system: Change 150-cm column to: 15-cm column |
CALCIPOTRIENE OINTMENT | IMPURITIES/Organic Impurities | USP40–NF35 | 3114 | 29-Sep-2017 | 1-Oct-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Footnote a of Table 1: Change (5Z,7Z,22E,24R)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3β,24-triol. to: (5Z,7Z,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3β,24-triol. |
CALCIUM ACETATE CAPSULES | PERFORMANCE TESTS/Dissolution <711> | Revision Bulletin (Official January 01, 2020) | Online | 28-Feb-2020 | 1-Mar-2020 | NA | NA | In Test 1/Analysis: Change dissolved at time point (i): Resulti = (rU/rS) × CS × V × D × (1/L) × 100 to: dissolved: … Read More |
CALCIUM AND VITAMIN D WITH MINERALS TABLETS | STRENGTH | USP43–NF38 | 4845 | 24-Apr-2020 | 1-May-2020 | NA | NA | In Calcium, Copper, Magnesium, Manganese, and Zinc, Method 2/Acceptance criteria: Change NLT 90.0%–125.0% to: 90.0%–125.0% |
CALCIUM ASCORBATE | IDENTIFICATION/A. | USPNF Online | Online | 26-May-2023 | 1-Aug-2023 | NA | NA | Change Characteristic emission lines for calcium at 184.0, 315.9, and 317.9 nm from the Sample solution correspond to those from the Standard solution, as obtained in the Assay. to: Characteristic emission lines for calcium at 184.0,… Read More |
CALCIUM ASCORBATE | ASSAY/Procedure | USPNF Online | Online | 30-Jun-2023 | 1-Aug-2023 | NA | NA | In Analysis: Change Mr1 = molecular weight of calcium ascorbate dihydrate, 426.43 to: Mr1 = molecular weight of calcium ascorbate dihydrate, 426.34 |
CALCIUM CARBONATE | IMPURITIES | USP36–NF31 | 2747 | 26-Jul-2013 | 1-Aug-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 1 of Acceptance criteria in Limit of Fluoride: Change 50 ppm to: NMT 50 ppm AND Line 1 of Acceptance criteria in Mercury, Method IIa <261>: Change 0.5 ppm to: NMT 0.5 ppm |
CALCIUM CARBONATE | IMPURITIES/Limit of Magnesium and Alkali Salts | USP42–NF37 | 666 | 30-Aug-2019 | 1-Sep-2019 | NA | NA | Change Sample solution: 1.0 g to: Sample: 1.0 g |
CALCIUM CITRATE MALATE | IMPURITIES/Limit of Fluoride | First Supplement to USP41–NF36 | 8299 | 29-Jun-2018 | 1-Jul-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 1 of Standard solution: Change Transfer 1.0 mL of Standard stock solution to: Transfer 2.0 mL of Standard stock solution |
CALCIUM GLUCONATE | CHEMICAL INFORMATION | USP39–NF34 | 2877 | 30-Sep-2016 | 1-Oct-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 5: Change [18016-24-5]. to: [66905-23-5]. |
CALCIUM GLUCONATE INJECTION | Identification | USP37–NF32 | 2089 | 26-Sep-2014 | 1-Oct-2014 | USP39–NF34 | First Supplement to USP38–NF33 | Line 1 of Identification test A: Change A volume of Injection diluted, if necessary, with water to obtain a test solution of calcium gluconate (1 in 100) responds to Identification test B under Calcium Gluconate. to: Dissolve a quantity of it in water to… Read More |
CALCIUM GLUCONATE INJECTION | DEFINITION | USP39–NF34 | 2879 | 30-Sep-2016 | 1-Oct-2016 | USP41–NF36 | First Supplement to USP40–NF35 | Line 8: Change It may contain sodium hydroxide added for adjustment of the pH. to: It may contain sodium hydroxide or hydrochloric acid added for adjustment of the pH. |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IDENTIFICATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In A. Spectroscopic Identification Tests <197>, Infrared Spectroscopy: 197K: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In System suitability solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS AND In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-… Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Related Compounds | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of USP Calcium DL-5-Methyltetrahydrofolate RS in the Standard solution (mg/mL) to: CS = concentration of USP Calcium D,L-5-Methyltetrahydrofolate RS in the … Read More |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Enantiomeric Purity | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Standard solution: Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change USP Calcium DL-5-Methyltetrahydrofolate RS to: USP Calcium D,L-5-Methyltetrahydrofolate RS |
CALCIUM LACTATE | CHEMICAL INFORMATION | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change Calcium lactate (1:2) hydrate to: Calcium lactate hydrate AND Change Calcium lactate (1:2) pentahydrate to: Calcium lactate pentahydrate |
CALCIUM LACTATE TABLETS | ASSAY/Procedure | USP38–NF33 | 2553 | 25-Sep-2015 | 1-Oct-2015 | USP40–NF35 | First Supplement to USP39–NF34 | Line 3 of Analysis: Change While stirring, add 30 mL of Titrant from a 50-mL buret. to: While stirring, add 15 mL of Titrant from a 50-mL buret. |
CALCIUM SACCHARATE | ASSAY/Procedure | USPNF 2021 ISSUE 1 | Online | 31-Dec-2021 | 1-Jan-2022 | NA | NA | In Analysis: Change Result = {[(VS − VB) × N × F]/W} × 100 to: Result = {[(VS − VB) × M × F]/W} × 100 AND Change … Read More |
CALCIUM SILICATE | IMPURITIES/Limit of Lead | USP41–NF36 | 5240 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In Lead standard solution: Change 1000 mg of lead/mL4 to: 1000 mg of lead/L4 |
CALCIUM STEARATE | IDENTIFICATION | USP40–NF35 | 7557 | 17-Nov-2017 | 1-Dec-2017 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 3 of B.: Change obtained in the Assay. to: obtained in the Assay for Content of Stearic Acid and Palmitic Acid. |
CALCIUM SULFATE | ASSAY/Procedure | First Supplement to USP36–NF31 | Online | 28-Mar-2014 | 1-Apr-2014 | USP38–NF33 | USP38–NF33 | Line 14 of Analysis: Change Result = [(V × N × F)/W] × 100 to: Result = [(V × M × F)/W] × 100 AND Line 15 of Analysis: Change V = volume of titrant consumed by the Sample (mL) N = actual… Read More |
CALCIUM SULFATE | SPECIFIC TESTS/Loss on Drying <731> | USP35–NF30 | 1724 | 29-Mar-2013 | 1-Apr-2013 | USP37–NF32 | USP37–NF32 | Line 1 of Acceptance criteria: Change NMT 1.5% for the anhydrous form and NMT 19.0%–23.0% for the dihydrate to: NMT 1.5% for the anhydrous form and 19.0%–23.0% for the dihydrate |
CALCIUM SULFATE | ASSAY/Procedure | USP35–NF30 | 1724 | 28-Sep-2012 | 1-Oct-2012 | USP37–NF32 | First Supplement to USP36–NF31 | Line 5 of Titrimetric system: Delete the subsection Blank: 100 mL of water and 4 mL of 3 N hydrochloric acid AND Line 11 of Analysis: Delete the sentence Perform a blank determination. AND Line 13 of Analysis: Change Result = [(V − B… Read More |
CALCIUM UNDECYLENATE | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Solution A: Change 0.15 N hydrochloric acid in water prepared as follows. Transfer 150 mL of hydrochloric acid to a 500-mL volumetric flask, dilute with water to volume, and mix well. to: 0.15 N hydrochloric acid in water prepared as follows.… Read More |
CANDESARTAN CILEXETIL | ASSAY/Procedure | USP36–NF31 | 2774 | 31-Jan-2014 | 1-Feb-2014 | USP38–NF33 | Second Supplement to USP37–NF32 | Line 1 of Analysis: Change Titrate with 8 mL of 0.1 N to: Titrate with 0.1 N |
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | ASSAY/Procedure/Chromatographic system | Second Supplement to USP41–NF36 | 8781 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In Column: Change [Note—Conditioning of the Column with Solution A and Solution B (80:20) to: [Note—Conditioning of the Column with Solution A and Solution B (90:10) |
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | IMPURITIES/Organic Impurities | USP39–NF34 | 2895 | 25-Mar-2016 | 1-Apr-2016 | USP40–NF35 | USP40–NF35 | Row 3 of Column 1 of Table 6:Change Candesartan related compound Ab,c to: Candesartan cilexetil related compound Ab,c |
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | ASSAY/Procedure/Chromatographic system | First Supplement to USP42–NF37 | Online | 26-Apr-2019 | 1-May-2019 | NA | NA | In Column: Change 4.6-mm × 15-cm; 5-µm packing L7. [Note—Conditioning of the Column with Solution A and Solution B ▲(90:10)▲ (ERR 1-Mar-2019) for about 30 min is recommended prior to use.] to: 4.6-mm × 15-cm… Read More |
CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE TABLETS | PERFORMANCE TESTS/Dissolution <711> | First Supplement to USP42–NF37 | Online | 26-Apr-2019 | 1-May-2019 | NA | NA | In Row 2 of Column 3 of Table 4: Change 0.014▲/0.028▲2S (USP41) to: 0.014 AND In Row 3 of Column 3 of Table 4: Change 0.014 to: 0.014/0.028 AND In Chromatographic… Read More |
CANDESARTAN CILEXETIL TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | Second Supplement to USP40–NF35 | 8730 | 29-Sep-2017 | 1-Oct-2017 | USP42–NF37 | First Supplement to USP41–NF36 | Line 2 of USP Candesartan Cilexetil Related Compound D RS: Change 1-{[(Cyclohexyloxycarbonyloxy)carbonyl]oxy}ethyl 3-{[2’-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate. to: 1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2’-(2-… Read More |
CAPRYLIC ACID | ASSAY/Procedure/Chromatographic system | USP43–NF38 | 5664 | 24-Apr-2020 | 1-May-2020 | NA | NA | In Column: Change 30-cm to: 30-m |
CAPRYLOCAPROYL POLYOXYLGLYCERIDES | IMPURITIES/Limit of Free Glycerol | USP36–NF31 | 1922 | 27-Sep-2013 | 1-Oct-2013 | USP38–NF33 | First Supplement to USP37–NF32 | Line 1 of Mode in Titrimetric system: Change Direct titration to: Residual titration AND Line 10 of Analysis: Change (VT − VB) to: (VB − VS) AND… Read More |
CAPSICUM OLEORESIN | SPECIFIC TESTS/Limit of Nonivamide | Second Supplement to USP36–NF31 | 6577 | 22-Nov-2013 | 1-Dec-2013 | USP38–NF33 | Second Supplement to USP37–NF32 | Line 1 of Acceptance criteria: Change on the dried basis to: on the anhydrous basis |
CAPTOPRIL | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF 2021 ISSUE 1 | Online | 19-Nov-2021 | 1-Dec-2021 | NA | NA | In USP Captopril Disulfide RS: Change L-Proline, 1,1ʹ-[dithiobis(2-methyl-1-oxo-3,1-propanediyl)]bis-[S-(R*,R*)]-. to: (2ʹS)-[(2S,2ʹS)-3,3ʹ-Disulfanediylbis(2-methylpropanoyl)]di-L-proline. |
CAPTOPRIL ORAL SOLUTION | Assay | USP35–NF30 | 2477 | 31-Jan-2013 | 1-Feb-2013 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 1 of Mobile phase: Change Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid. to: Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas. |
CAPTOPRIL ORAL SUSPENSION | Assay | USP35–NF30 | 2477 | 31-Jan-2013 | 1-Feb-2013 | USP37–NF32 | Second Supplement to USP36–NF31 | Line 1 of Mobile phase: Change Prepare a filtered and degassed mixture of methanol and water (11:9) containing 0.5 mL of phosphoric acid. to: Methanol and water (55:45) containing 0.5 mL/L of phosphoric acid. Filter, and degas. |
CARAWAY OIL | DEFINITION | USP36–NF31 | 1924 | 31-May-2013 | 1-Jun-2013 | USP37–NF32 | USP37–NF32 | Line 3: Change It contains NMT 50.0% of d-carvone (C10H14O). to: It contains NLT 50.0% of d-carvone (C10H14O). |
CARBAMAZEPINE EXTENDED-RELEASE TABLETS | ASSAY/Procedure | USP37–NF32 | 2123 | 30-May-2014 | 1-Jun-2014 | USP38–NF33 | USP38–NF33 | Line 2 of Sample stock solution B: Change Standard stock solution to: Sample stock solution A |
CARBAMAZEPINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In USP Carbamazepine Related Compound A RS: Change 238.28 to: 238.29 AND In USP Carbamazepine Related Compound B RS: Change 193.24 to: 193.25 AND In USP 9-Methylacridine RS: Change 193.24 to: 193.25 |
CARBIDOPA | ASSAY/Procedure | USP39–NF34 | 2924 | 18-Nov-2016 | 1-Dec-2016 | USP41–NF36 | Second Supplement to USP40–NF35 | Line 3: Change Mobile phase: Alcohol and 0.05 M monobasic sodium phosphate, adjusted with phosphoric acid to a pH of 2.7 (5:95) to: Buffer: 0.05 M monobasic sodium phosphate, adjusted with phosphoric acid to a pH of 2.7 Mobile phase: Alcohol and Buffer (5:… Read More |
CARBIDOPA AND LEVODOPA ORALLY DISINTEGRATING TABLETS | ASSAY | Second Supplement to USP36–NF31 | 6580 | 28-Mar-2014 | 1-Apr-2014 | USP38–NF33 | USP38–NF33 | Line 2 of Procedure: Change Inject the Sample solution within 2 h of preparation. Protect the volumetric solutions from light. to: Protect the volumetric solutions from light. |
CARBIDOPA AND LEVODOPA TABLETS | ASSAY/Procedure/Chromatographic system | USP41–NF36 | 693 | 25-May-2018 | 1-Jun-2018 | USP42–NF37 | Second Supplement to USP41–NF36 | Line 1 of Detector: Change Identification B, to: Identification A, |
CARBINOXAMINE MALEATE | IMPURITIES/Organic Impurities | Second Supplement to USP41–NF36 | 8786 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In Standard stock solution: Change (equivalent to 0.05 mg/mL of USP Carbinoxamine Maleate RS free base) and 0.05 mg/mL each of USP Carbinoxamine Related Compound A RS, USP Carbinoxamine Related Compound B RS, and USP Carbinoxamine Related Compound C RS… Read More |
CARBINOXAMINE MALEATE TABLETS | IMPURITIES/Organic Impurities | Second Supplement to USP41–NF36 | 8788 | 22-Feb-2019 | 1-Mar-2019 | NA | NA | In the Standard stock solution: Change USP Carbinoxamine Maleate RS free base) to: carbinoxamine) AND In the Standard solution: Change USP Carbinoxamine Maleate RS free base) to: carbinoxamine) AND In the Analysis… Read More |
CARBOMER COPOLYMER | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Limit of Ethyl Acetate and Cyclohexane/Analysis: Change Samples: Standard stock solution, Standard solution A, Standard solution B, Standard solution C, and Sample solution to: Samples: Standard solution A, Standard… Read More |
CARBOMER COPOLYMER | CHEMICAL INFORMATION | USPNF 2021 ISSUE 1 | Online | 26-Mar-2021 | 1-May-2021 | NA | NA | See online.uspnf.com for correction |
CARBOMER HOMOPOLYMER | IMPURITIES | USPNF 2021 ISSUE 1 | Online | 28-May-2021 | 1-Jun-2021 | NA | NA | In Limit of Ethyl Acetate and Cyclohexane/Analysis: Change Samples: Standard stock solution, Standard solution A, Standard solution B, Standard solution C, and Sample solution to: Samples: Standard solution A, Standard… Read More |